{
    "nct_id": "NCT05607017",
    "official_title": "The Role of Losartan in the Prevention of Early Structural Changes Associated With Radiation-Induced Heart Failure",
    "inclusion_criteria": "->18 years of age\n\n* Non-metastatic Breast Cancer patients who are scheduled to receive conventional left breast/chest wall RT inclusive of treatment to the internal mammary lymph nodes (IMNs)\n* Prior chemotherapy is permitted\n* Patients must have Left-sided Breast Cancer\n* Ability to understand and the willingness to sign a written informed consent document\n* No contraindication to MRI\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Person who is pregnant or breastfeeding.\n* Patient unable to swallow oral medication.\n* Patients receiving any other investigational agent will not be excluded from study eligibility, unless the patient is already enrolled in an interventional study evaluating cardiac toxicity\n* Patients already receiving ACE/ARBs.\n* Patients with a history of allergic reactions to Losartan biosimilars.",
    "miscellaneous_criteria": ""
}